Durect Corp (DRRX)

Feb 15, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated at StockNews.com - Defense World

Feb 15, 2025

Feb 10, 2025

DURECT (NASDAQ:DRRX) Research Coverage Started at StockNews.com - Defense World

Feb 10, 2025

Feb 04, 2025

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference - Yahoo Finance

Feb 04, 2025

Jan 30, 2025

StockNews.com Initiates Coverage on DURECT (NASDAQ:DRRX) - Defense World

Jan 30, 2025

Jan 28, 2025

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence - Stockhouse Publishing

Jan 28, 2025

Jan 28, 2025

Revolutionary Liver Disease Drug Cuts Death Risk by More Than Half in US Patients - StockTitan

Jan 28, 2025

Jan 22, 2025

DURECT (NASDAQ:DRRX) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 22, 2025

Jan 16, 2025

Durect (DRRX) Upgraded to Strong Buy: Here's Why - Yahoo Finance

Jan 16, 2025

Jan 14, 2025

DURECT (NASDAQ:DRRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

Jan 14, 2025

Jan 13, 2025

Geode Capital Management LLC Has $429,000 Holdings in DURECT Co. (NASDAQ:DRRX) - Defense World

Jan 13, 2025

Jan 11, 2025

DURECT faces Nasdaq delisting over share price - Investing.com

Jan 11, 2025

Jan 09, 2025

New Strong Buy Stocks for January 9th - Yahoo Finance

Jan 09, 2025

Dec 27, 2024

Reviewing Acerus Pharmaceuticals (OTCMKTS:TRLPF) and DURECT (NASDAQ:DRRX) - Defense World

Dec 27, 2024

Dec 16, 2024

Microbial Products Market Size to Hit USD 351.42 Bn by 2034 - Precedence Research

Dec 16, 2024

Dec 11, 2024

Durect (DRRX) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Dec 11, 2024

Dec 02, 2024

DURECT Corp expected to post a loss of 17 cents a shareEarnings Preview - XM

Dec 02, 2024

Nov 28, 2024

Is BellRing Brands (BRBR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Nov 28, 2024

Nov 26, 2024

DURECT Corp sells ALZET product line to Lafayette - TradingPedia

Nov 26, 2024

Nov 25, 2024

Durect announces sale of Alzet line of osmotic pumps to LIC for $17.5M - TipRanks

Nov 25, 2024

Nov 25, 2024

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million - PR Newswire

Nov 25, 2024

Nov 15, 2024

DURECT Corporation (NASDAQ:DRRX) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 14, 2024

Earnings call: DURECT Corporation reports Q3 2024 financials - Investing.com

Nov 14, 2024

Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Gro - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... By GuruFocus - Investing.com Canada

Nov 14, 2024

Nov 14, 2024

Durect: Q3 Earnings Snapshot - Houston Chronicle

Nov 14, 2024

Nov 13, 2024

Durect Corp Q3 2024 Earnings: GAAP EPS of -$0.14 Misses Estimates, Revenue at $1.9 Million Below Expectations - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 13, 2024

Nov 13, 2024

Durect reports Q3 EPS (14c), consensus (17c) - TipRanks

Nov 13, 2024

Nov 13, 2024

DURECT Q3: $4.3M Loss, Plans Phase 3 Trial Amid Funding Needs & License Agreement End | DRRX Stock News - StockTitan

Nov 13, 2024

Nov 06, 2024

DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update - StockTitan

Nov 06, 2024

Oct 18, 2024

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances - Citeline News & Insights

Oct 18, 2024

Oct 17, 2024

DRRXDurect Corp Latest Stock News & Market Updates - StockTitan

Oct 17, 2024

Oct 17, 2024

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024 - StockTitan

Oct 17, 2024

Oct 09, 2024

Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Gro - GuruFocus.com

Oct 09, 2024

Oct 09, 2024

Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ... - Yahoo Finance

Oct 09, 2024

Sep 26, 2024

Durect Corp Annual Meeting Decisions and Shareholder Votes - TipRanks

Sep 26, 2024

Sep 26, 2024

H.C. Wainwright maintains Neutral rating on Durect shares post FDA meeting - Investing.com

Sep 26, 2024

Sep 25, 2024

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis - PR Newswire

Sep 25, 2024

Sep 10, 2024

BAT NE turnover rate (A), BAT temperature (B), representative BAT... - ResearchGate

Sep 10, 2024

Sep 04, 2024

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference - PR Newswire

Sep 04, 2024

Aug 23, 2024

Durect Corp (NQ: DRRX - Financial Content

Aug 23, 2024

Aug 15, 2024

DURECT Corporation (NASDAQ:DRRX) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 15, 2024

Aug 13, 2024

DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update - PR Newswire

Aug 13, 2024

Aug 07, 2024

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update - Yahoo Finance

Aug 07, 2024

Jun 29, 2024

Durect - The Pharma Letter

Jun 29, 2024

May 21, 2024

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis - PR Newswire

May 21, 2024

May 14, 2024

DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript - Insider Monkey

May 14, 2024

May 13, 2024

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update - PR Newswire

May 13, 2024

May 08, 2024

Durect and Sandoz signs a $293 mln development and commercialization agreement for Posimir - Reuters

May 08, 2024

Apr 30, 2024

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis - PR Newswire

Apr 30, 2024